Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Efficacy of MP1032 in hospitalised patients with COVID-19- authors' reply.
Lancet Reg Health Eur. 2024 Feb 2;38:100857. doi: 10.1016/j.lanepe.2024.100857. eCollection 2024 Mar.
Lancet Reg Health Eur. 2024.
PMID: 38328414
Free PMC article.
No abstract available.
Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial.
Sager P, Kaiser A, Schumann S, Ludescher B, Niedermaier M, Schmidt I, Och K, Dings C, Lehr T, Brysch W.
Sager P, et al. Among authors: ludescher b.
Lancet Reg Health Eur. 2023 Dec 6;37:100810. doi: 10.1016/j.lanepe.2023.100810. eCollection 2024 Feb.
Lancet Reg Health Eur. 2023.
PMID: 38076629
Free PMC article.
Item in Clipboard
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19.
Schumann S, Kaiser A, Nicoletti F, Mangano K, Fagone P, van Wijk E, Yan Y, Schulz P, Ludescher B, Niedermaier M, von Wegerer J, Rauch P, Setz C, Schubert U, Brysch W.
Schumann S, et al. Among authors: ludescher b.
Int J Mol Sci. 2020 Nov 20;21(22):8803. doi: 10.3390/ijms21228803.
Int J Mol Sci. 2020.
PMID: 33233817
Free PMC article.
Item in Clipboard
Cite
Cite